Out of 175 different outcomes researchers included in the study, they found people who took GLP-1 medications had lower risks of 42 different health outcomes and higher risks for 19
Our dedicated team is ready to help you reach your health goals with tailored, compassionate care that prioritizes your well-being
As the trials progress, CagriSema could become a key player in the field of obesity treatment, offering a potent option for individuals struggling to lose weight
Until then, patients should focus on safe, available, evidence-based care
The near-term impact may be neutral to negative, with some consumers provided with an alternative route to losing weight
If you have specific concerns or a situation arises in which you require medical advice, you should consult with an appropriately trained and qualified medical services provider.